For years Canndoc has been successfully supplying medical cannabis-based products that providing efficient treatment for children diagnosed with autism spectrum disorder Canndoc’s medicinal cannabis clinical pipeline includes 9 approved Phase 2 clinical trials...
ClearFlow, Inc., a medical device company based in Irvine, California, has announced positive clinical trial results published in the peer-reviewed Journal of Cardiothoracic Surgery. The trial evaluated the use of the PleuraFlow® Active Clearance Technology® (ACT®)...
Key Points Immuron completes first meeting with FDA on development of IMM-124E as product to specifically prevent Travelers’ Diarrhea (TD) Phase 3 clinical trial of IMM-124E to prevent TD planned for 2020 Previous clinical trial data on IMM-124E from earlier studies...
Enrollment Rate Exceeds Expectation, Suggesting High Unmet Need and Anticipation for Bermekimab in HS AUSTIN, Texas, Nov. 19, 2019 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) today announces rapid enrollment in its randomized, double-blind,...
– MOMENTUM trial designed to confirm the unique benefits of momelotinib on all three hallmarks of myelofibrosis: symptoms, anemia and enlarged spleen — Targeting enrollment of 180 symptomatic and anemic patients previously treated with a JAK inhibitor –-...
Email
Text